BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 3048805)

  • 1. Nonimmune human cells can express MHC class II antigens in the absence of invariant chain--an immunohistological study on normal and chronically inflamed small intestine.
    Momburg F; Koretz K; Von Herbay A; Möller P
    Clin Exp Immunol; 1988 Jun; 72(3):367-72. PubMed ID: 3048805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential induction of MHC antigens on autochthonous cells of ileum affected by Crohn's disease.
    Koretz K; Momburg F; Otto HF; Möller P
    Am J Pathol; 1987 Dec; 129(3):493-502. PubMed ID: 3425689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and function of class II antigens on gastric carcinoma cells and gastric epithelia: differential expression of DR, DQ, and DP antigens.
    Sakai K; Takiguchi M; Mori S; Kobori O; Morioka Y; Inoko H; Sekiguchi M; Kano K
    J Natl Cancer Inst; 1987 Nov; 79(5):923-32. PubMed ID: 2960847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Class II MHC antigen expression in the atherosclerotic plaque: smooth muscle cells express HLA-DR, HLA-DQ and the invariant gamma chain.
    Hansson GK; Jonasson L; Holm J; Claesson-Welsh L
    Clin Exp Immunol; 1986 May; 64(2):261-8. PubMed ID: 3527502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-DR, DP and DQ expression in the small intestine of patients with coeliac disease.
    Marley NJ; Macartney JC; Ciclitira PJ
    Clin Exp Immunol; 1987 Nov; 70(2):386-93. PubMed ID: 3322617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA class II molecules (HLA-DR, -DP, -DQ) on cells in the human CNS studied in situ and in vitro.
    Ulvestad E; Williams K; Bø L; Trapp B; Antel J; Mørk S
    Immunology; 1994 Aug; 82(4):535-41. PubMed ID: 7835916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of HLA class II antigens in fetal human spleen: relationship of HLA-DP, DQ, and DR to immunoglobulin expression.
    Edwards JA; Durant BM; Jones DB; Evans PR; Smith JL
    J Immunol; 1986 Jul; 137(2):490-7. PubMed ID: 3522732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA class II antigen expression in human papillomavirus-associated cervical cancer.
    Glew SS; Duggan-Keen M; Cabrera T; Stern PL
    Cancer Res; 1992 Jul; 52(14):4009-16. PubMed ID: 1377602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of HLA-DR, HLA-DP, HLA-DQ and associated invariant chain (Ii) in normal colorectal mucosa, adenoma and carcinoma.
    Degener T; Momburg F; Möller P
    Virchows Arch A Pathol Anat Histopathol; 1988; 412(4):315-22. PubMed ID: 3125670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA class II expression in normal and inflamed conjunctiva.
    Lee SJ; Rice BA; Foster CS
    Reg Immunol; 1990-1991; 3(4):177-85. PubMed ID: 2129602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of MHC class II molecules HLA-DR, -DP and -DQ and ICAM 1 in human podocytes by gamma-interferon.
    Baudeau C; Delarue F; Hé CJ; Nguyen G; Adida C; Peraldi MN; Sraer JD; Rondeau E
    Exp Nephrol; 1994; 2(5):306-12. PubMed ID: 7812737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MHC antigen expression in human oral squamous carcinoma cell lines.
    Mutlu S; Matthews JB; Midda M; Scully C; Prime SS
    J Pathol; 1991 Oct; 165(2):129-36. PubMed ID: 1744799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-co-ordinate expression of HLA-DR antigens and invariant chain.
    Momburg F; Möller P
    Immunology; 1988 Mar; 63(3):551-3. PubMed ID: 3280476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in the expression of major histocompatibility complex class II antigens in liver allograft rejection.
    Hubscher SG; Adams DH; Elias E
    J Pathol; 1990 Oct; 162(2):165-71. PubMed ID: 2250195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human retinal pigment epithelial cells differentially express MHC class II (HLA, DP, DR and DQ) antigens in response to in vitro stimulation with lymphokine or purified IFN-gamma.
    Liversidge JM; Sewell HF; Forrester JV
    Clin Exp Immunol; 1988 Sep; 73(3):489-94. PubMed ID: 3145163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of HLA-DR, -DQ, and -DP antigens on malignant B cells.
    Pesando JM; Graf L
    J Immunol; 1986 Jun; 136(11):4311-8. PubMed ID: 2939141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts.
    Maurer DH; Hanke JH; Mickelson E; Rich RR; Pollack MS
    J Immunol; 1987 Aug; 139(3):715-23. PubMed ID: 3110281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of class II MHC gene products by fallopian tube epithelium in pregnancy and throughout the menstrual cycle.
    Bulmer JN; Earl U
    Immunology; 1987 Jun; 61(2):207-13. PubMed ID: 3298023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotinamide and 3-aminobenzamide reduce interferon-gamma-induced class II MHC (HLA-DR and -DP) molecule expression on cultured human endothelial cells and fibroblasts.
    Otsuka A; Hanafusa T; Miyagawa J; Kono N; Tarui S
    Immunopharmacol Immunotoxicol; 1991; 13(3):263-80. PubMed ID: 1834724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-surface expression of human histocompatibility leucocyte antigen (HLA) class II-associated invariant chain (CD74) does not always correlate with cell-surface expression of HLA class II molecules.
    Wilson KM; Labeta MO; Pawelec G; Fernandez N
    Immunology; 1993 Jun; 79(2):331-5. PubMed ID: 8344710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.